To identify agents specifically targeting the SDHA overexpressing ovarian cancer cells, we utilized a custom compound library (from Seleckchem) composed of 64 anti-metabolic compounds (Supplementary Table S2). This evidence concerns the gene SDHA and ovarian cancer.